|
1
|
Lupsa BC and Insogna K: Bone health and
osteoporosis. Endocrinol Metab Clin North Am. 44:517–530.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gkastaris K, Goulis DG, Potoupnis M,
Anastasilakis AD and Kapetanos G: Obesity, osteoporosis and bone
metabolism. J Musculoskelet Neuronal Interact. 20:372–381.
2020.PubMed/NCBI
|
|
3
|
Li Z, Xue H, Tan G and Xu Z: Effects of
miRNAs, lncRNAs and circRNAs on osteoporosis as regulatory factors
of bone homeostasis (Review). Mol Med Rep. 24(788)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ala M, Jafari RM and Dehpour AR: Diabetes
mellitus and osteoporosis correlation: Challenges and hopes. Curr
Diabetes Rev. 16:984–1001. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kurra S, Fink DA and Siris ES:
Osteoporosis-associated fracture and diabetes. Endocrinol Metab
Clin North Am. 43:233–243. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Napoli N, Chandran M, Pierroz DD,
Abrahamsen B, Schwartz AV and Ferrari SL: IOF Bone and Diabetes
Working Group. Mechanisms of diabetes mellitus-induced bone
fragility. Nat Rev Endocrinol. 13:208–219. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Eller-Vainicher C, Cairoli E, Grassi G,
Grassi F, Catalano A, Merlotti D, Falchetti A, Gaudio A, Chiodini I
and Gennari L: Pathophysiology and management of type 2 diabetes
mellitus bone fragility. J Diabetes Res.
2020(7608964)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Garcia-Martin A, Rozas-Moreno P,
Reyes-Garcia R, Morales-Santana S, García-Fontana B, García-Salcedo
JA and Muñoz-Torres M: Circulating levels of sclerostin are
increased in patients with type 2 diabetes mellitus. J Clin
Endocrinol Metab. 97:234–241. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Balint E, Szabo P, Marshall CF and Sprague
SM: Glucose-induced inhibition of in vitro bone mineralization.
Bone. 28:21–28. 2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lecka-Czernik B: Bone loss in diabetes:
Use of antidiabetic thiazolidinediones and secondary osteoporosis.
Curr Osteoporos Rep. 8:178–184. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gallwitz B: GLP-1 receptor agonists in
type 2 diabetes and beyond-New insights 2015. Eur Endocrinol.
11:21–25. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mabilleau G, Gobron B, Bouvard B and
Chappard D: Incretin-based therapy for the treatment of bone
fragility in diabetes mellitus. Peptides. 100:108–113.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bjarnason NH, Henriksen EE, Alexandersen
P, Christgau S, Henriksen DB and Christiansen C: Mechanism of
circadian variation in bone resorption. Bone. 30:307–313.
2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lamari Y, Boissard C, Moukhtar MS,
Jullienne A, Rosselin G and Garel JM: Expression of glucagon-like
peptide 1 receptor in a murine C cell line: Regulation of
calcitonin gene by glucagon-like peptide 1. FEBS Lett. 393:248–252.
1996.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yamada C, Yamada Y, Tsukiyama K, Yamada K,
Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y and Inagaki
N: The murine glucagon-like peptide-1 receptor is essential for
control of bone resorption. Endocrinology. 149:574–579.
2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mabilleau G, Mieczkowska A, Irwin N, Flatt
PR and Chappard D: Optimal bone mechanical and material properties
require a functional glucagon-like peptide-1 receptor. J
Endocrinol. 219:59–68. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mieczkowska A, Mansur S, Bouvard B, Flatt
PR, Thorens B, Irwin N, Chappard D and Mabilleau G: Double incretin
receptor knock-out (DIRKO) mice present with alterations of
trabecular and cortical micromorphology and bone strength.
Osteoporos Int. 26:209–218. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Pereira M, Jeyabalan J, Jorgensen CS,
Hopkinson M, Al-Jazzar A, Roux JP, Chavassieux P, Orriss IR,
Cleasby ME and Chenu C: Chronic administration of Glucagon-like
peptide-1 receptor agonists improves trabecular bone mass and
architecture in ovariectomised mice. Bone. 81:459–467.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fu LJ, Tang TT, Hao YQ and Dai KR:
Long-term effects of alendronate on fracture healing and bone
remodeling of femoral shaft in ovariectomized rats. Acta Pharmacol
Sin. 34:387–392. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vashghani Farahani MM, Masteri Farahani R,
Mostafavinia A, Abbasian MR, Pouriran R, Noruzian M, Ghoreishi SK,
Aryan A and Bayat M: Effect of pentoxifylline administration on an
experimental rat model of femur fracture healing with
intramedullary fixation. Iran Red Crescent Med J.
17(e29513)2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Barron RL, Oster G, Grauer A, Crittenden
DB and Weycker D: Determinants of imminent fracture risk in
postmenopausal women with osteoporosis. Osteoporos Int.
31:2103–2111. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kim M, Kim JH, Hong S, Kwon B, Kim EY,
Jung HS and Sohn Y: Effects of Melandrium firmum Rohrbach on
RANKL-induced osteoclast differentiation and OVX rats. Mol Med Rep.
24(610)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mohd-Tahir NA and Li SC: Economic burden
of osteoporosis-related hip fracture in Asia: A systematic review.
Osteoporos Int. 28:2035–2044. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Renno AC, de Moura FM, dos Santos NS,
Tirico RP, Bossini PS and Parizotto NA: Effects of 830-nm laser,
used in two doses, on biomechanical properties of osteopenic rat
femora. Photomed Laser Surg. 24:202–206. 2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kim CS, Yea K, Morrell CN, Jeong Y and
Lowenstein CJ: Estrogen activates endothelial exocytosis. Biochem
Biophys Res Commun. 558:29–35. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ibrahim N, Mohamed N and Shuid AN: Update
on statins: Hope for osteoporotic fracture healing treatment. Curr
Drug Targets. 14:1524–1532. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Nuche-Berenguer B, Portal-Nunez S, Moreno
P, González N, Acitores A, López-Herradón A, Esbrit P, Valverde I
and Villanueva-Peñacarrillo ML: Presence of a functional receptor
for GLP-1 in osteoblastic cells, independent of the cAMP-linked
GLP-1 receptor. J Cell Physiol. 225:585–592. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Pacheco-Pantoja EL, Ranganath LR,
Gallagher JA, Wilson PJ and Fraser WD: Receptors and effects of gut
hormones in three osteoblastic cell lines. BMC Physiol.
11(12)2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim JY, Lee SK, Jo KJ, Song DY, Lim DM,
Park KY, Bonewald LF and Kim BJ: Exendin-4 increases bone mineral
density in type 2 diabetic OLETF rats potentially through the
down-regulation of SOST/sclerostin in osteocytes. Life Sci.
92:533–540. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bell GI, Sanchez-Pescador R, Laybourn PJ
and Najarian RC: Exon duplication and divergence in the human
preproglucagon gene. Nature. 304:368–371. 1983.PubMed/NCBI View
Article : Google Scholar
|
|
31
|
Lovshin JA and Drucker DJ: Incretin-based
therapies for type 2 diabetes mellitus. Nat Rev Endocrinol.
5:262–269. 2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Nauck MA: Incretin-based therapies for
type 2 diabetes mellitus: Properties, functions, and clinical
implications. Am J Med. 124 (1 Suppl):S3–S18. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Holst JJ: The physiology of glucagon-like
peptide 1. Physiol Rev. 87:1409–1439. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zheng Y, Xiao Y, Zhang D, Zhang S, Ouyang
J, Li L, Shi W, Zhang R, Liu H, Jin Q, et al: Geniposide
ameliorated dexamethasone-induced cholesterol accumulation in
osteoblasts by mediating the GLP-1R/ABCA1 axis. Cells.
10(3424)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lee HM, Joo BS, Lee CH, Kim HY, Ock JH and
Lee YS: Effect of glucagon-like peptide-1 on the differentiation of
adipose-derived stem cells into osteoblasts and adipocytes. J
Menopausal Med. 21:93–103. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Nuche-Berenguer B, Moreno P, Portal-Nunez
S, Dapia S, Esbrit P and Villanueva-Penacarrillo ML: Exendin-4
exerts osteogenic actions in insulin-resistant and type 2 diabetic
states. Regul Pept. 159:61–66. 2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Orriss IR, Taylor SE and Arnett TR: Rat
osteoblast cultures. Methods Mol Biol. 816:31–41. 2012.PubMed/NCBI View Article : Google Scholar
|
